Katherine Michaelis, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cachexia | 8 | 2021 | 198 | 1.990 |
Why?
|
Toll-Like Receptor 7 | 3 | 2021 | 177 | 0.940 |
Why?
|
I-kappa B Proteins | 4 | 2014 | 212 | 0.660 |
Why?
|
Pancreatic Neoplasms | 6 | 2021 | 5349 | 0.560 |
Why?
|
Imidazoles | 2 | 2019 | 1180 | 0.550 |
Why?
|
Hyperoxia | 2 | 2014 | 250 | 0.490 |
Why?
|
Gonadotrophs | 2 | 2011 | 19 | 0.480 |
Why?
|
Microglia | 3 | 2020 | 1350 | 0.470 |
Why?
|
NF-kappa B | 4 | 2014 | 2486 | 0.420 |
Why?
|
Lung Injury | 2 | 2014 | 424 | 0.410 |
Why?
|
Membrane Glycoproteins | 2 | 2021 | 3709 | 0.400 |
Why?
|
Carcinoma, Pancreatic Ductal | 2 | 2020 | 1722 | 0.390 |
Why?
|
Toll-Like Receptor 8 | 2 | 2019 | 100 | 0.320 |
Why?
|
Pituitary Neoplasms | 3 | 2012 | 1313 | 0.320 |
Why?
|
Antigens, Differentiation | 1 | 2011 | 911 | 0.310 |
Why?
|
Illness Behavior | 2 | 2018 | 23 | 0.290 |
Why?
|
Tumor Microenvironment | 1 | 2019 | 3844 | 0.270 |
Why?
|
Locomotion | 2 | 2019 | 387 | 0.260 |
Why?
|
Myeloid Differentiation Factor 88 | 3 | 2019 | 581 | 0.250 |
Why?
|
OX40 Ligand | 1 | 2024 | 55 | 0.240 |
Why?
|
Hypothalamus | 3 | 2020 | 998 | 0.230 |
Why?
|
Croup | 1 | 2022 | 23 | 0.210 |
Why?
|
Apoptosis | 3 | 2014 | 9497 | 0.190 |
Why?
|
Tumor Suppressor Proteins | 1 | 2011 | 2802 | 0.190 |
Why?
|
Antigen-Presenting Cells | 1 | 2024 | 967 | 0.180 |
Why?
|
Mice | 18 | 2024 | 81209 | 0.180 |
Why?
|
Tachyphylaxis | 1 | 2019 | 54 | 0.170 |
Why?
|
Appetite | 1 | 2021 | 247 | 0.160 |
Why?
|
Neuroglia | 2 | 2021 | 944 | 0.160 |
Why?
|
Ganglia, Spinal | 1 | 2021 | 523 | 0.160 |
Why?
|
Neutrophil Infiltration | 2 | 2020 | 393 | 0.160 |
Why?
|
Follistatin | 1 | 2018 | 137 | 0.150 |
Why?
|
Mice, Knockout | 7 | 2021 | 14374 | 0.140 |
Why?
|
Muscle Development | 1 | 2018 | 259 | 0.140 |
Why?
|
Sensory Receptor Cells | 1 | 2021 | 509 | 0.140 |
Why?
|
Mice, Inbred ICR | 2 | 2014 | 364 | 0.140 |
Why?
|
Animals | 20 | 2024 | 167960 | 0.140 |
Why?
|
Adaptor Proteins, Vesicular Transport | 1 | 2018 | 306 | 0.130 |
Why?
|
Muscles | 2 | 2021 | 1581 | 0.130 |
Why?
|
Inflammation | 6 | 2020 | 10755 | 0.130 |
Why?
|
Leukocytosis | 1 | 2017 | 251 | 0.130 |
Why?
|
Tumor Burden | 2 | 2019 | 1895 | 0.130 |
Why?
|
Myeloid Cells | 1 | 2020 | 821 | 0.120 |
Why?
|
Lipopolysaccharides | 2 | 2019 | 2209 | 0.120 |
Why?
|
Respiratory Tract Infections | 1 | 2022 | 1007 | 0.120 |
Why?
|
Drug Carriers | 1 | 2018 | 709 | 0.110 |
Why?
|
Signal Transduction | 7 | 2019 | 23374 | 0.110 |
Why?
|
Cytokines | 3 | 2019 | 7344 | 0.110 |
Why?
|
Energy Metabolism | 3 | 2020 | 2869 | 0.100 |
Why?
|
Eating | 1 | 2019 | 1539 | 0.100 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18137 | 0.100 |
Why?
|
Central Nervous System | 1 | 2019 | 1334 | 0.100 |
Why?
|
I-kappa B Kinase | 1 | 2013 | 251 | 0.100 |
Why?
|
Sequence Analysis, RNA | 1 | 2019 | 2005 | 0.100 |
Why?
|
Behavior, Animal | 1 | 2019 | 1866 | 0.100 |
Why?
|
Body Composition | 2 | 2019 | 2419 | 0.100 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3075 | 0.090 |
Why?
|
Lung | 3 | 2014 | 9994 | 0.090 |
Why?
|
Prolactinoma | 1 | 2011 | 113 | 0.090 |
Why?
|
Immune Tolerance | 1 | 2019 | 2299 | 0.090 |
Why?
|
Gene Expression | 2 | 2021 | 7587 | 0.090 |
Why?
|
Cell Line, Tumor | 4 | 2021 | 16932 | 0.090 |
Why?
|
Anorexia | 2 | 2021 | 154 | 0.090 |
Why?
|
Macrophages | 2 | 2021 | 5745 | 0.080 |
Why?
|
Mice, Inbred C57BL | 4 | 2021 | 22020 | 0.080 |
Why?
|
Ki-67 Antigen | 1 | 2011 | 631 | 0.080 |
Why?
|
Genes, p53 | 1 | 2011 | 713 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2012 | 3774 | 0.080 |
Why?
|
Body Weight | 1 | 2019 | 4611 | 0.080 |
Why?
|
Mice, Transgenic | 2 | 2020 | 9530 | 0.080 |
Why?
|
RNA, Viral | 1 | 2016 | 2838 | 0.070 |
Why?
|
Anemia | 1 | 2017 | 1511 | 0.070 |
Why?
|
Immunity, Innate | 1 | 2019 | 3047 | 0.070 |
Why?
|
Nanoparticles | 1 | 2018 | 1943 | 0.070 |
Why?
|
Testosterone | 1 | 2017 | 2470 | 0.070 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4550 | 0.060 |
Why?
|
Cells, Cultured | 2 | 2019 | 18955 | 0.060 |
Why?
|
RNA, Messenger | 2 | 2018 | 12762 | 0.060 |
Why?
|
Fetus | 1 | 2013 | 1859 | 0.060 |
Why?
|
Biopsy | 1 | 2017 | 6771 | 0.060 |
Why?
|
Survival Rate | 1 | 2019 | 12810 | 0.060 |
Why?
|
Glycoproteins | 1 | 2012 | 2208 | 0.060 |
Why?
|
Inflammation Mediators | 1 | 2013 | 1881 | 0.060 |
Why?
|
Liver | 1 | 2018 | 7510 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3085 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3205 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9424 | 0.050 |
Why?
|
Female | 11 | 2021 | 391246 | 0.050 |
Why?
|
DNA Damage | 1 | 2011 | 2442 | 0.050 |
Why?
|
Fibroblasts | 1 | 2012 | 4089 | 0.050 |
Why?
|
Male | 10 | 2021 | 359718 | 0.050 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2011 | 2924 | 0.050 |
Why?
|
Endothelium, Vascular | 1 | 2013 | 4434 | 0.050 |
Why?
|
Adenoma | 1 | 2011 | 2148 | 0.050 |
Why?
|
Oxidative Stress | 1 | 2012 | 3106 | 0.050 |
Why?
|
Cell Line | 2 | 2012 | 15620 | 0.040 |
Why?
|
Receptor, Melanocortin, Type 4 | 1 | 2021 | 128 | 0.040 |
Why?
|
Cell Cycle Proteins | 1 | 2012 | 3448 | 0.040 |
Why?
|
Hospitalization | 1 | 2020 | 10789 | 0.040 |
Why?
|
Guinea Pigs | 1 | 2021 | 1316 | 0.040 |
Why?
|
Receptors, CCR2 | 1 | 2020 | 215 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2012 | 8512 | 0.040 |
Why?
|
Gliosis | 1 | 2020 | 244 | 0.040 |
Why?
|
Gene Expression Regulation | 2 | 2014 | 11902 | 0.040 |
Why?
|
Brain | 3 | 2020 | 26951 | 0.040 |
Why?
|
Animals, Newborn | 2 | 2014 | 2671 | 0.040 |
Why?
|
Neutrophils | 2 | 2021 | 3767 | 0.040 |
Why?
|
Chemokine CCL2 | 1 | 2020 | 605 | 0.040 |
Why?
|
Cell Proliferation | 3 | 2024 | 10442 | 0.040 |
Why?
|
Forkhead Transcription Factors | 1 | 2024 | 1613 | 0.040 |
Why?
|
Injections, Subcutaneous | 1 | 2018 | 680 | 0.040 |
Why?
|
Organ Size | 1 | 2021 | 2254 | 0.030 |
Why?
|
RNA, Double-Stranded | 1 | 2016 | 295 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1019 | 0.030 |
Why?
|
Humans | 11 | 2024 | 760613 | 0.030 |
Why?
|
Lymphocyte Activation | 1 | 2024 | 5496 | 0.030 |
Why?
|
Gene Deletion | 1 | 2021 | 2668 | 0.030 |
Why?
|
Body Temperature | 1 | 2016 | 777 | 0.030 |
Why?
|
Models, Biological | 2 | 2021 | 9468 | 0.030 |
Why?
|
Muscle, Skeletal | 2 | 2019 | 4924 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 36286 | 0.020 |
Why?
|
Culture Media, Serum-Free | 1 | 2012 | 148 | 0.020 |
Why?
|
G2 Phase | 1 | 2012 | 133 | 0.020 |
Why?
|
Up-Regulation | 1 | 2021 | 4122 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58980 | 0.020 |
Why?
|
Graft vs Host Disease | 1 | 2024 | 3026 | 0.020 |
Why?
|
Metabolic Networks and Pathways | 1 | 2016 | 788 | 0.020 |
Why?
|
Mitotic Index | 1 | 2011 | 161 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 544 | 0.020 |
Why?
|
Bone Marrow | 1 | 2021 | 2914 | 0.020 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2012 | 435 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2019 | 3583 | 0.020 |
Why?
|
Gene Knock-In Techniques | 1 | 2012 | 419 | 0.020 |
Why?
|
Cell Line, Transformed | 1 | 2012 | 869 | 0.020 |
Why?
|
Cavernous Sinus | 1 | 2011 | 123 | 0.020 |
Why?
|
Superoxide Dismutase | 1 | 2013 | 594 | 0.020 |
Why?
|
Pituitary Gland | 1 | 2012 | 637 | 0.020 |
Why?
|
Infant | 2 | 2022 | 36053 | 0.020 |
Why?
|
Motor Activity | 1 | 2019 | 2688 | 0.020 |
Why?
|
Feeding Behavior | 1 | 2021 | 3185 | 0.020 |
Why?
|
Weight Loss | 1 | 2020 | 2684 | 0.020 |
Why?
|
Mice, Mutant Strains | 1 | 2012 | 1754 | 0.020 |
Why?
|
Hippocampus | 1 | 2021 | 3738 | 0.020 |
Why?
|
Skull Base | 1 | 2011 | 291 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2012 | 1055 | 0.020 |
Why?
|
CpG Islands | 1 | 2012 | 1221 | 0.020 |
Why?
|
Cytoplasm | 1 | 2012 | 1516 | 0.020 |
Why?
|
Aged | 3 | 2021 | 169143 | 0.020 |
Why?
|
Gene Expression Profiling | 2 | 2012 | 9406 | 0.020 |
Why?
|
Obesity | 2 | 2020 | 12919 | 0.020 |
Why?
|
Chronic Disease | 1 | 2020 | 9288 | 0.020 |
Why?
|
Middle Aged | 3 | 2021 | 220359 | 0.020 |
Why?
|
Antioxidants | 1 | 2013 | 1667 | 0.020 |
Why?
|
Adult | 3 | 2021 | 220007 | 0.020 |
Why?
|
Cell Division | 1 | 2012 | 4463 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4571 | 0.010 |
Why?
|
Antiviral Agents | 1 | 2016 | 3061 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2011 | 3618 | 0.010 |
Why?
|
Child | 2 | 2022 | 79799 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6065 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15840 | 0.010 |
Why?
|
Cell Survival | 1 | 2012 | 5797 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2013 | 8158 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2012 | 5782 | 0.010 |
Why?
|
Radiography | 1 | 2011 | 6965 | 0.010 |
Why?
|
Pandemics | 1 | 2020 | 8623 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26179 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 64981 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11070 | 0.010 |
Why?
|
Child, Preschool | 1 | 2020 | 42056 | 0.010 |
Why?
|
Rats | 1 | 2013 | 23709 | 0.010 |
Why?
|
Quality of Life | 1 | 2016 | 13308 | 0.010 |
Why?
|
Risk Factors | 1 | 2020 | 74333 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2011 | 9278 | 0.010 |
Why?
|
United States | 1 | 2020 | 72448 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 87809 | 0.010 |
Why?
|
Pregnancy | 1 | 2012 | 29746 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 40139 | 0.010 |
Why?
|
Neoplasms | 1 | 2018 | 22075 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2011 | 80345 | 0.000 |
Why?
|